Investing Profile

David Rubin

VCInvestor
Managing Director at Merck Global Health Innovation Fund
msdghifund.comUnited States
Photo of David Rubin, Managing Director at Merck Global Health Innovation Fund

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
20
CompanyStageDateRound SizeTotal Raised
Turbine
Series BFeb 2026$25M
Series ANov 2022$21M
$160M
Co-investors: Barath Shankar Subramanian (Accel), Anvesh Ramineni (MassMutual Ventures), Alexandre Perrin (Enauto Ventures), Hany Nada (ACME Capital), Daniel Waterhouse (Balderton Capital), Esther Dyson (HealthWorldWeb LLC), Christian Dahlen (Band of Angels), Vishal Gulati (Molten Ventures), Richard De Silva
Octave
Series CSep 2025$36M
Series BJul 2023$33M
Series UnknownOct 2021
$190M
Co-investors: Julian Harris (Deerfield Management), Saurabh Bhansali (Health Velocity Capital), Mike Pellini (Section 32), Michael Rubin (Northpond Ventures)
N-Power Medicine
Series BMay 2024$72M
$72M
Baseimmune
Series AFeb 2024$11M
$17M
Co-investors: Jamie Macfarlane (Creator Fund), Hussein Kanji (Hoxton Ventures)
Culmination Bio
Series ANov 2023$10M
$10M
Co-investors: Jack Boren
PreciseDx
Series AJan 2022$11M
$14M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds)
Verge Genomics
Series BDec 2021$98M
$130M
Co-investors: Lan Xuezhao (Basis Set Ventures), Chris Sklarin (Alumni Ventures ), Andrew Boszhardt (Great Oaks Venture Capital), Jesse Beyroutey (IA Ventures), Elad Gil (Think Colorado), Henry McNamara (Great Oaks Venture Capital), Kimberly Vogel Reynik, Kimberly Vogel
Saama
Private EquityOct 2021